| Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis. | |
| | |
MedLine Citation:
|
PMID: 20364117 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pigment epithelium-derived factor (PEDF), an angiogenesis inhibitor with multiple other functions, balances angiogenesis in the eye and blocks tumor progression. Cervical cancer, an angiogenesis-dependent tumor, is the second most common cancer in women without effective treatment. It has been reported that PEDF can inhibit several types of tumors, however, the potential of PEDF for the treatment of cervical carcinoma has not been well explored. The present study was designed to investigate the effect of recombinant PEDF on the neovascularization and growth of cervical carcinoma. We found for the first time that PEDF was downregulated apparently in human cervical carcinoma nests compared to either normal cervical epithelium or nonneoplastic peritumoral epithelium, suggesting potential anti-angiogenesis function by supplement of PEDF in cervical carcinoma. Intraperitoneal injection of PEDF in xenografted cervical carcinoma mice suppressed tumor growth with 68% reduction. Microvessel density in tumor tissues treated with PEDF was significantly decreased. PEDF dose-dependently inhibited proliferation and induced apoptosis of endothelial cells, but had no direct effect on proliferation and apoptosis of Hela cells under both normoxia and hypoxia. These results suggested that PEDF suppressed tumor growth by blocking angiogenesis instead of a direct cytotoxic effect on tumor cells. VEGF, a major angiogenic stimulator, was downregulated by PEDF in Hela cells by downregulation of HIF-1α, a crucial transcriptional factor for VEGF expression. Downregulation of VEGF expression in tumor cells through inhibiting HIF-1α, thus attenuating the paracrine effect of VEGF on endothelial cells, may represent a mechanism for the anti-angiogenic activity of PEDF. |
| | |
Authors:
|
Jun Yang; Shuqin Chen; Xuan Huang; Jiande Han; Qingsong Wang; Dingbo Shi; Rui Cheng; Guoquan Gao; Xia Yang |
Related Documents
:
|
20033377 - Chemokines. 11438567 - Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growt... 22068227 - How stereological analysis of vascular morphology can quantify the blood volume fractio... 15927357 - A new family of angiogenic factors. 3900097 - Investigation of adenylate energy charge, phosphorylation potential, and atp concentrat... 8013407 - Nonmutagenic carcinogens induce intrachromosomal recombination in dividing yeast cells. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-06-08 |
Journal Detail:
|
Title: Cancer biology & therapy Volume: 9 ISSN: 1555-8576 ISO Abbreviation: Cancer Biol. Ther. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-09-21 Completed Date: 2011-02-18 Revised Date: 2011-03-30 |
Medline Journal Info:
|
Nlm Unique ID: 101137842 Medline TA: Cancer Biol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 967-74 Citation Subset: IM |
Affiliation:
|
Department of Biochemistry, Zhongshan Medical School of Sun Yat-sen University, Guangzhou, Guangdong Province, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiogenesis Inhibitors
/
pharmacology,
therapeutic use* Animals Apoptosis / drug effects Cell Hypoxia / drug effects Down-Regulation Endothelial Cells / drug effects Eye Proteins / pharmacology, therapeutic use* Female Hela Cells Humans Hypoxia-Inducible Factor 1, alpha Subunit / metabolism Mice Neovascularization, Pathologic / drug therapy Nerve Growth Factors / pharmacology, therapeutic use* Recombinant Proteins / therapeutic use Serpins / pharmacology, therapeutic use* Tumor Burden / drug effects Uterine Cervical Neoplasms / blood supply, drug therapy*, metabolism, pathology Vascular Endothelial Growth Factor A / metabolism Xenograft Model Antitumor Assays |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inhibitors; 0/Eye Proteins; 0/Hypoxia-Inducible Factor 1, alpha Subunit; 0/Nerve Growth Factors; 0/Recombinant Proteins; 0/Serpins; 0/Vascular Endothelial Growth Factor A; 0/pigment epithelium-derived factor |
| Comments/Corrections | |
Comment In:
|
Cancer Biol Ther. 2010 Jun;9(12):975-7
[PMID:
20424516
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: 2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells.
Next Document: hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.